ArticleScientific reports2026
A novel potential method for early diagnosis of Sjogren's syndrome: lacrimal gland color doppler ultrasonography.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Primary Sjogren's Syndrome (pSS) is characterized by earlier and more frequently involved in the lacrimal gland (LG). This study used lacrimal gland color doppler ultrasonography (LGCDUS) to explore changes in both structure and blood flow of LG in early-stage pSS patients. This is a retrospective case-control study which included 24 patients with pSS and 26 healthy controls. The size of LGs including major, minor and sagittal diameter and the hemodynamics of lacrimal artery including peak systolic velocity (PSV), end-diastolic velocities (EDV), and resistance index (RI), quantitatively analyzing and comparing were between the two groups based on LGCDUS. In the pSS group, correlation analysis was conducted among various parameters of LG and pSS. To evaluate the diagnostic efficacy of parameters of LG, the area under the receiver operating characteristic (ROC) curve was measured. The early-stage pSS patients showed significantly increased EDV, and decreased RI of LG (P < 0.0083, after Bonferroni correction). The LG sagittal diameter showed a significant positive correlation with C-reactive protein (CRP) (P < 0.00049, after Bonferroni correction). The LGCDUS parameters for diagnosis showed an area under the curve (AUC) of 0.764. This study observed that LGCDUS can detect damage, the systemic activity and ocular surface changes in early-stage pSS patients. Therefore, LGCDUS provides not only a new method for evaluating pathological changes and functions of LGs, but also a new and feasible technical means for diagnosing and management of pSS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.